Sensei Biotherapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Sensei Biotherapeutics has a total shareholder equity of $64.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $74.4M and $9.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$65.76m |
| Equity | US$64.90m |
| Total liabilities | US$9.48m |
| Total assets | US$74.37m |
Recent financial health updates
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03
We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14We're Hopeful That Sensei Biotherapeutics (NASDAQ:SNSE) Will Use Its Cash Wisely
Aug 14Recent updates
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14We're Hopeful That Sensei Biotherapeutics (NASDAQ:SNSE) Will Use Its Cash Wisely
Aug 14Sensei Biotherapeutics GAAP EPS of -$0.34 beats by $0.06
Aug 09Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Apr 18Sensei Biotherapeutics (NASDAQ:SNSE) Is In A Good Position To Deliver On Growth Plans
Nov 16Financial Position Analysis
Short Term Liabilities: SNSE's short term assets ($67.3M) exceed its short term liabilities ($5.6M).
Long Term Liabilities: SNSE's short term assets ($67.3M) exceed its long term liabilities ($3.8M).
Debt to Equity History and Analysis
Debt Level: SNSE is debt free.
Reducing Debt: SNSE currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SNSE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SNSE has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 23.2% each year.